Resonant Capital Advisors, LLC Zoetis Inc. Transaction History
Resonant Capital Advisors, LLC
- $1.54 Billion
- Q2 2025
A detailed history of Resonant Capital Advisors, LLC transactions in Zoetis Inc. stock. As of the latest transaction made, Resonant Capital Advisors, LLC holds 2,382 shares of ZTS stock, worth $348,772. This represents 0.02% of its overall portfolio holdings.
Number of Shares
2,382
Previous 2,063
15.46%
Holding current value
$348,772
Previous $339,000
9.44%
% of portfolio
0.02%
Previous 0.02%
Shares
20 transactions
Others Institutions Holding ZTS
# of Institutions
2,130Shares Held
430MCall Options Held
1.47MPut Options Held
1.45M-
Vanguard Group Inc Valley Forge, PA41.9MShares$6.13 Billion0.11% of portfolio
-
Black Rock Inc. New York, NY36.8MShares$5.39 Billion0.15% of portfolio
-
State Street Corp Boston, MA19.7MShares$2.89 Billion0.12% of portfolio
-
Morgan Stanley New York, NY17.7MShares$2.59 Billion0.19% of portfolio
-
State Farm Mutual Automobile Insurance CO Bloomington, IL15.9MShares$2.33 Billion2.21% of portfolio
About Zoetis Inc.
- Ticker ZTS
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 468,139,008
- Market Cap $68.5B
- Description
- Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...